Cdn.ymaws.com



Nurse Practitioner Formulary?New Mexico Nurse Practitioner CouncilRevised May 2017INTRODUCTIONThe New Mexico Board of Nursing (NMBON) requires nurse practitioners (NPs) to maintain a formulary as stated below (16.12.2.13N(5)(b) Formulary):It is the CNP’s responsibility to maintain a formulary of dangerous drugs and controlled substances that may be prescribed; the only drugs to be included in the formulary are those relevant to the CNP’s specialty and practice setting. The board of nursing reserves the right to audit the formulary of the CNP. Licensees may be subject to disciplinary action by the board of nursing if non-compliant with the audit.The New Mexico Nurse Practitioner Council developed this formulary based on pharmacologic categories.1 In those cases where a category includes only one or two drugs, the formulary lists those individual drugs alphabetically at the end of the category listing (alphabetic structure disregards hyphens throughout entire document). This formulary is one option to meet the requirement referenced above; NPs may choose to use this or any other formulary they determine meets their individual needs and/or requirements.Use of this formulary indicates understanding and acceptance of the following:The NMBON requires nurse practitioners to maintain a formulary and to comply with an audit of their formulary.Users will mark only those pharmacologic categories that include drugs relevant to their specialty and practice setting.Pharmacology is a developing science. Users should review this formulary periodically to keep it relevant to their current practice and note the date of each review below their signature. Additionally, users should date all additions, deletions or other changes made during each review.Some pharmacologic categories include controlled substances; prescribing those substances requires federal DEA licensure and a New Mexico state controlled substances license. It is the user’s responsibility to maintain compliance with this requirement.Prescribers must maintain appropriate knowledge about drugs, including (but not limited to) proper dosing, route of administration, contraindications, drug interactions and controlled substance status.This formulary may not be all-inclusive, given the many ways drugs may be categorized; users are responsible for adding any necessary categories and/or drugs they prescribe in their practice.Categories are inclusive of available combination agents.This formulary is not inclusive of over-the-counter (OTC) or herbal therapies and does not preclude prescription of those agents.1Reference: 2017 Wolters Kluwer Clinical Drug Information, Inc. Lexicomp? (Lexi-Drugs, Pharmacologic Category). Version: 4.0.1.PERSONAL INFORMATIONNAME FORMTEXT ?????CNP NM LICENSE # FORMTEXT ?????SPECIALTY FORMTEXT ?????PRACTICE SETTING FORMTEXT ????? CERTIFICATION 1 FORMTEXT ?????CERTIFICATION 2 FORMTEXT ?????CERTIFICATION AGENCY FORMTEXT ?????CERTIFICATION AGENCY FORMTEXT ?????NUMBER FORMTEXT ?????NUMBER FORMTEXT ?????EXPIRATION DATE FORMTEXT ?????EXPIRATION DATE FORMTEXT ?????CERTIFICATION 3 FORMTEXT ?????CERTIFICATION 4 FORMTEXT ?????CERTIFICATION AGENCY FORMTEXT ?????CERTIFICATION AGENCY FORMTEXT ?????NUMBER FORMTEXT ?????NUMBER FORMTEXT ?????EXPIRATION DATE FORMTEXT ?????EXPIRATION DATE FORMTEXT ?????My signature below indicates that I have carefully reviewed this formulary and included only the categories and/or individual drugs relevant to my specialty and practice setting in this formulary.Signature FORMTEXT ?????Date FORMTEXT ?????Reviewed:Date FORMTEXT ?????Initials FORMTEXT ?????Date FORMTEXT ?????Initials FORMTEXT ?????Date FORMTEXT ?????Initials FORMTEXT ?????Date FORMTEXT ?????Initials FORMTEXT ?????Date FORMTEXT ?????Initials FORMTEXT ?????FORMULARYNUMERICAL FORMCHECKBOX 5 Alpha-Reductase Inhibitors FORMCHECKBOX 5-Aminosalicylic Acid (ASA) DerivativesA FORMCHECKBOX Abortifacients FORMCHECKBOX Acetylcholinesterase Inhibitors FORMCHECKBOX Acne Products FORMCHECKBOX Adrenergic Agonist Agents FORMCHECKBOX Alkalinizing Agents FORMCHECKBOX Alkylamine Derviatives FORMCHECKBOX Allergen-Specific Immunotherapy FORMCHECKBOX Alpha2-Adrenergic Agonists FORMCHECKBOX Alpha-Adrenergic Agonists FORMCHECKBOX Alpha-/Beta Agonists FORMCHECKBOX Amebicides FORMCHECKBOX Ammonium Detoxicant FORMCHECKBOX Analgesics, Non-opioid – may include combination agents FORMCHECKBOX Analgesics, Opioid – may include combination agents (such as Suboxone which requires mandated training before prescribing) FORMCHECKBOX Androgens FORMCHECKBOX Anesthetics – may include local and topical FORMCHECKBOX Anorexiants – may include serotonin 5-HT2C receptor agonist agent FORMCHECKBOX Antacids FORMCHECKBOX Antiandrogens FORMCHECKBOX Antianginal Agents FORMCHECKBOX Antianxiety Agents FORMCHECKBOX Antiarrhythmic Agents – may include Class I (a, b & c), Class II, Class III, Class IV, and miscellaneous agents FORMCHECKBOX Antibacterial Agents – may include topical and dental agents FORMCHECKBOX Antibiotic Agents – application forms may include intranasal, irrigation, ophthalmic, oral, otic and topical agents; subcategories may include aminoglycoside, carbapenem, cephalosporin, cyclic lipopetide, fluoroquinolone, glycylcycline, ketolide, lincosamide, macrolide, monobactam, oxazolidinone, penicillin, pleuromutilin, streptogramin, sulfonamide derivative, tetracycline derivative and miscellaneous agents FORMCHECKBOX Antibiotic/Corticosteroid Combinations – application forms may include ophthalmic, otic and topical agents FORMCHECKBOX Antibody, Monoclonal – may include antiasthmatic, complement inhibitor, selective adhesion-molecule inhibitor agents FORMCHECKBOX Antibody, Polyclonal FORMCHECKBOX Anticholinergic Agents FORMCHECKBOX Anticoagulants – may include direct oral (DOAC), direct thrombin inhibitor, factor Xa inhibitor, heparin, heparinoid, and low molecular weight heparin agents FORMCHECKBOX Anticonvulsants – may include barbiturate, benzodiazepine, hydantoin, neuronal potassium channel opener, succinimide, triazole derivative and miscellaneous agents FORMCHECKBOX Anticystine Agents FORMCHECKBOX Antidepressants – may include alpha-2 antagonist, dopamine/norepinephrine-reuptake inhibitor, monoamine oxidase inhibitor (and MOI reversible), selective serotonin reuptake inhibitor, serotonin 5-HT1A receptor agonist, serotonin 5-HT3 receptor antagonist, serotonin reuptake inhibitor/antagonist, serotonin/norepinephrine reuptake inhibitor, tetracyclic and tricyclic agents FORMCHECKBOX Antidiabetic Agents – may include alpha-glucosidase inhibitor, biguanide, dipeptidyl peptidase 4 (DPP-4) inhibitor, dopamine agonist, glucagon-like peptide-1 (GLP-1) receptor agonist, meglitinide analog, sodium-glucose cotransporter 2 (SGLT2) inhibitor, sulfonylurea and thiazolidinedione agents FORMCHECKBOX Antidiarrheals FORMCHECKBOX Antidiuretic Hormone (ADH) Analog FORMCHECKBOX Antidotes – may include extravasation and hypoglycemia agents FORMCHECKBOX Antiemetics – may include histamine antagonist, selective 5-HT3 receptor antagonist and substance P/Neurokinin 1 receptor antagonist agents FORMCHECKBOX Antifibrinolytic Agents FORMCHECKBOX Antiflatulents FORMCHECKBOX Antifungal Agents – application forms may include ophthalmic, oral, parenteral, topical and vaginal agents; subcategories may include azole and imidazole derivative agents FORMCHECKBOX Antigout Agents FORMCHECKBOX Antihelmintics FORMCHECKBOX Antihemophilic Agents FORMCHECKBOX Antihepacivirals (Anti-HCV) – may include NS5A inhibitor, nucleoside, polymerase inhibitor, and protease inhibitor agents FORMCHECKBOX Antihepadnavirals (Anti-HBV) – may include nucleoside and nucleotide reverse transcriptase inhibitor agents FORMCHECKBOX Antihypertensive Agents – may include alpha1 blocker, alpha2-adrenergic agonist, angiotensin II receptor blocker (ARB), angiotensin-converting enzyme (ACE) inhibitor, beta-blocker, calcium channel blocker (dihydropyridine and nondihydrophyridine), diuretic, ganglionic blocking, mineralocorticoid (aldosterone) receptor antagonist, renin inhibitor and vasodilator agents FORMCHECKBOX Anti-inflammatory Agents – application forms may include ophthalmic, oral, otic and locally applied agents FORMCHECKBOX Antilipemic Agents – may include 2-azetidinone, bile acid sequestrant, fibric acid, HMG-CoA reductase inhibitor, microsomal triglyceride transfer protein (MTP) inhibitor, omega-3 fatty acid, PCSK9 inhibitor and miscellaneous agents FORMCHECKBOX Antimalarial Agents FORMCHECKBOX Antimanic Agents FORMCHECKBOX Antimigraine Agents – may include serotonin 5-HT1B, 1D receptor agonist agents FORMCHECKBOX Antineoplastic Agents – may include alkylating, anaplastic lymphoma kinase inhibitor, anthracenedione, antracycline, anti-CD, anti GD2, anti-HER2, anti-PD monoclonal antibody, anti-SLAMF7, antiandrogen, antibiotic, antibody drug conjugate, antimetabolite, antimicrotubular, aromatase inhibitor, BCL-2 inhibitor, biological response modulator, camptothecin, cephalotaxine, cyclin-dependent kinase inhibitor, DNA methylation inhibitor, enzyme, epidermal growth factor receptor (EGFR) inhibitor, epothilone B analog, estrogen receptor antagonist, gonadotropin-releasing hormone inhibitor, hedgehog pathway inhibitor, hormone, hormone antagonist, immune checkpoint inhibitor, Janus associated kinase inhibitor, MEK inhibitor, miscellaneous, monoclonal antibody, mTOR kinase inhibitor, oncolytic virus, PARP inhibitor, PDGFR-alpha blocker, platinum analog, podophyllotoxin derivative, proteasome inhibitor, protein synthesis inhibitor, retinoic acid derivative, taxane derivative, topoisomerase inhibitor, tyrosine kinase inhibitor, vascular endothelial growth factor (VEGF) inhibitor and vinca alkaloid agents FORMCHECKBOX Antiparasitic Agents FORMCHECKBOX Anti-Parkinson Agents – may include anticholinergic, COMT inhibitor, decarboxylase inhibitor, dopamine agonist, dopamine precursor and MAO type B inhibitor agents FORMCHECKBOX Antiplatelet Agents – may include cyclopentyltriazolopyrimidine, glycoprotein IIb/IIIa inhibitor, non-thienopyridine and theinopyridine, and protease-activated receptor-1 antagonist agents FORMCHECKBOX Antiprotozoals FORMCHECKBOX Antipsoriatic Agents FORMCHECKBOX Antipsychotics – including typical and atypical FORMCHECKBOX Antiretroviral (Anti-HIV) Agents – may include CCR5 antagonist, fusion protein inhibitor, integrase inhibitor, protease inhibitor and reverse transcriptase inhibitor (non-nucleoside and nucleoside) agents FORMCHECKBOX Antirheumatic Agents – may include disease modifying, gold compound and miscellaneous agents FORMCHECKBOX Antiseptics – may include ophthalmic, oral, topical and vaginal agents FORMCHECKBOX Antispasmodic Agents – may include gastrointestinal and urinary agents FORMCHECKBOX Antithyroid Agents FORMCHECKBOX Antitoxins FORMCHECKBOX Antitrypsin Deficiency Agent FORMCHECKBOX Antitubercular Agents FORMCHECKBOX Antitussives FORMCHECKBOX Antivenin FORMCHECKBOX Antiviral Agents – may include adamantine, neuraminidase inhibitor, ophthalmic, oral and topical agents FORMCHECKBOX Appetite Stimulants FORMCHECKBOX AstringentsB FORMCHECKBOX Barbiturates FORMCHECKBOX Benzodiazepines FORMCHECKBOX Beta2 Agonists FORMCHECKBOX Beta2-Adrenergic Agonists FORMCHECKBOX Bile Acids FORMCHECKBOX Biological Response Modulators FORMCHECKBOX Bisphosphonate Derivatives FORMCHECKBOX Blood Product DerivativesC FORMCHECKBOX C1 Esterase Inhibitors FORMCHECKBOX Calcium Salts FORMCHECKBOX Caloric Agents FORMCHECKBOX Carbonic Anhydrase Inhibitors FORMCHECKBOX Central Nervous System Stimulants FORMCHECKBOX Chelating Agents FORMCHECKBOX Chemoprotective Agents FORMCHECKBOX Cholinergic Agonists FORMCHECKBOX Contraceptives FORMCHECKBOX Contrast Agents FORMCHECKBOX Corticosteroids – may include oral inhalant, nasal, ophthalmic, otic, rectal, systemic and topical agents FORMCHECKBOX Cosmetic Agent, Implants FORMCHECKBOX Cytochrome P-450 InhibitorsD FORMCHECKBOX Decongestants FORMCHECKBOX Dental Gases FORMCHECKBOX Diagnostic Agents FORMCHECKBOX Dietary Supplements FORMCHECKBOX Diuretics – may include carbonic anhydrase inhibitor, loop, osmotic, potassium sparing, thiazide and thiazide related agentsE FORMCHECKBOX Electrolyte Supplements – may include oral and parenteral agents FORMCHECKBOX Enzymes – may include co-factor, inhibitors, gastrointestinal, replacement therapy, topical debridement and urate-oxidase (recombinant) agents FORMCHECKBOX Ergot Derivatives FORMCHECKBOX Estrogens – may include derivative agents FORMCHECKBOX ExpectorantsF FORMCHECKBOX Fibrinolytic AgentG FORMCHECKBOX Gastrointestinal Agents – may include prokinetic, stimulant and miscellaneous agents FORMCHECKBOX Genitourinary Irrigants FORMCHECKBOX Glycopeptides FORMCHECKBOX Gonadotropin Agents FORMCHECKBOX Gonadotropin-Releasing Hormone Agonists FORMCHECKBOX Gonadotropin-Releasing Hormone FORMCHECKBOX Growth Hormones – may include receptor antagonist and releasing factor agentsH FORMCHECKBOX Hemostatic Agents FORMCHECKBOX Histamine Antagonists FORMCHECKBOX Hormones – may include antagonist and posterior pituitary agents FORMCHECKBOX Hypnotic AgentsI FORMCHECKBOX Immune Globulins FORMCHECKBOX Immunomodulator Agents – may include systemic and topical agents FORMCHECKBOX Immunosuppressant Agents FORMCHECKBOX Inotropes FORMCHECKBOX Insulins – may include intermediate-acting, long-acting, rapid-acting and short-acting agents FORMCHECKBOX Interferon FORMCHECKBOX Interleukin Inhibitors – may include interleukin-1, -2, -12, -23 and -1 beta agents FORMCHECKBOX Interleukin Receptor Antagonists – may include interleukin-1, -4, -5 and -6 agents FORMCHECKBOX Intravenous Nutritional Therapy FORMCHECKBOX Iodinated Contrast Media FORMCHECKBOX Iron SaltsK FORMCHECKBOX Keratolytic AgentsL FORMCHECKBOX Laxatives – may include bowel evacuant, bulk-producing, lubricant, osmotic, saline, stimulant and miscellaneous agents FORMCHECKBOX Leukotriene Receptor Antagonists FORMCHECKBOX Lipoxygenase Inhibitor FORMCHECKBOX Lung SurfactantM FORMCHECKBOX Magnesium Salt FORMCHECKBOX Mast Cell Stabilizers FORMCHECKBOX Medical FoodsN FORMCHECKBOX N-Methyl-D-Aspartate (NMDA) Receptor Antagonists FORMCHECKBOX Neuromuscular Blocker Agents FORMCHECKBOX Nonsteroidal Anti-inflammatory Drugs (NSAIDs) – may include COX-2 selective, nasal, ophthalmic, oral, parenteral and topical agents FORMCHECKBOX Nutritional SupplementsO FORMCHECKBOX Ophthalmic Agents – may include antiglaucoma, miotic, mydriatic, toxin, vascular endothelial growth factor (VEGF), vasoconstrictor, viscoelastic and miscellaneous agents FORMCHECKBOX Opioid Antagonists FORMCHECKBOX Otic Agents – may include analgesic, anti-infective and cerumenolytic agents FORMCHECKBOX Ovulation StimulatorsP FORMCHECKBOX Parathyroid Hormone Analogs FORMCHECKBOX Pediculocides FORMCHECKBOX Phosphate Binders FORMCHECKBOX Phosphodiesterase Enzyme Inhibitors – may include phosphodiesterase-3, -4, -5, nonselective and topical agents FORMCHECKBOX Plasma Volume Expanders, Colloid FORMCHECKBOX Probiotics FORMCHECKBOX Progestins FORMCHECKBOX Prostacyclins FORMCHECKBOX Prostaglandins FORMCHECKBOX Protectants, Topical FORMCHECKBOX Proton Pump InhibitorsR FORMCHECKBOX Radiological/Contrast Media – may include ionic (high and low osmolality), nonionic (high, iso and low osmolality) and paramagnetic agents FORMCHECKBOX Radiopharmaceuticals FORMCHECKBOX Respiratory Stimulants FORMCHECKBOX Retinoic Acid DerivativesS FORMCHECKBOX Salicylates FORMCHECKBOX Scabicidal Agents FORMCHECKBOX Sclerosing Agents FORMCHECKBOX Selective Estrogen Receptor Modulators (SERMs) FORMCHECKBOX Skeletal Muscle Relaxants FORMCHECKBOX Skin and Mucous Membrane Agents FORMCHECKBOX Smoking Cessation Aids FORMCHECKBOX Somatostatin AnalogsT FORMCHECKBOX Thrombolytic Agents FORMCHECKBOX Thyroid Products FORMCHECKBOX Topical Skin Products – may include acne, antibacterial, photosensitizing, skin and mucous membrane agents FORMCHECKBOX Trace Elements, Parenteral FORMCHECKBOX Tumor Necrosis Factor (TNF) Blocking AgentsU FORMCHECKBOX Urea Cycle Disorder (UCD) Treatment Agents FORMCHECKBOX Urinary Tract ProductsV FORMCHECKBOX Vaccines FORMCHECKBOX Vasodilators – may include direct-acting, peripheral and pulmonary agents FORMCHECKBOX Vitamins – includes fat and water soluble agents FORMCHECKBOX Vitamin D AnalogsINDIVIDUAL DRUG LISTMost drugs listed below are the only agent (or one of only two agents) in a category. A few drugs listed below may be one of many in a category but have a specific therapeutic use not shared by other drugs in that category. FORMCHECKBOX acamprosate (GABA Agonist/Glutamate Antagonist) FORMCHECKBOX acetylcysteine (Antidote; Mucolytic Agent) FORMCHECKBOX allopurinol (Xanthine Oxidase Inhibitor) FORMCHECKBOX alosetron (Selective 5-HT3 Receptor Antagonist) FORMCHECKBOX atomoxetine (Norepinephrine Reuptake Inhibitor, Selective) FORMCHECKBOX barium (Radiopaque Agent) FORMCHECKBOX becaplermin (Growth Factor, Platelet-Derived) FORMCHECKBOX belatacept (Selective T-Cell Costimulation Blocker) FORMCHECKBOX betaine (Homocystinuria, Treatment Agent) FORMCHECKBOX cinacalcet (Calcimimetic) FORMCHECKBOX collagenase (Debridement Agent, Topical, Enzyme) FORMCHECKBOX conivaptan (Vasopressin Antagonist) FORMCHECKBOX dalfampridine (Potassium Channel Blocker) FORMCHECKBOX denosumab (Bone-Modifying Agent) FORMCHECKBOX deoxycholic acid (Lipolytic) FORMCHECKBOX desmedetomidine (Sedative) FORMCHECKBOX desmopressin (Vasopressin Analog, Synthetic) FORMCHECKBOX digoxin (Cardiac Glycoside) FORMCHECKBOX disulfiram (Aldehyde Dehydrogenase Inhibitor) FORMCHECKBOX dornase alfa (Mucolytic Agent) FORMCHECKBOX ecallantide (Kallikrein Inhibitor) FORMCHECKBOX fingolimod (Sphingosine 1-Phosphate [S1P] Receptor Modulator) FORMCHECKBOX flibanserin (Mixed 5-HT1A Agonist/5-HT2A Antagonist) FORMCHECKBOX gabapentin (GABA Analog) FORMCHECKBOX glatiramer (Biological, Miscellaneous) FORMCHECKBOX glutamine (Amino Acid) FORMCHECKBOX hyroquinone (Depigmenting Agent) FORMCHECKBOX icatibant (Selective Bradykinin B2 Receptor Antagonist) FORMCHECKBOX icodextrine (Adhesiolytic; Peritoneal Dialysate) FORMCHECKBOX isoproterenol (Beta1/Beta2 Agonist) FORMCHECKBOX ivabradine (Cardiovascular Agent, Miscellaneous) FORMCHECKBOX ivacaftor (Cystic Fibrosis Transmembrane Conductance Regulator Potentiator) FORMCHECKBOX leucovorin/levoleucovorin (Chemotherapy Modulating Agent) FORMCHECKBOX methoxsalen (Psoralen) FORMCHECKBOX methylene blue (Phenothiazine Derivative) FORMCHECKBOX metreleptin (Leptin Analog) FORMCHECKBOX metyrosine (Tyrosine Hydroxylase Inhibitor) FORMCHECKBOX midodrine (Alpha1 Agonist) FORMCHECKBOX mifepristone (Cortisol Receptor Blocker) FORMCHECKBOX mipomersent (Antihyperlipidemic Agent, Apolipoprotein B Antisense Oligonucleotide) FORMCHECKBOX mirabegron (Beta3 Agonist) FORMCHECKBOX nesiritide (Natriuretic Peptide, B-type, Human) FORMCHECKBOX nimodipine (Calcium Channel Blocker) FORMCHECKBOX nintedanib (Tyrosine Kinase Inhibitor) FORMCHECKBOX nitisinone (4-Hydroxyphenylpyruvate Dioxygenase Inhibitor) FORMCHECKBOX obeticholic acid (Farnesoid X Receptor [FXR] Agonist) FORMCHECKBOX oprelvekin (Human Growth Factor) FORMCHECKBOX orlistat (Lipase Inhibitor) FORMCHECKBOX oxytocin (Oxytocic Agent) FORMCHECKBOX oxymetholone (Anabolic Steroid) FORMCHECKBOX palifermin (Keratinocyte Growth Factor) FORMCHECKBOX panhematin (Blood Modifier) FORMCHECKBOX paralydehyde (Anxiolytic, Sedative and Hypnotic, Miscellaneous) FORMCHECKBOX pentoxifylline (Blood Viscosity Reducer Agent) FORMCHECKBOX phenylephrine, systemic (Alpha-Adrenergic Agonist) FORMCHECKBOX pinaverium (Calcium Channel Antagonist, Gastrointestinal) FORMCHECKBOX pirfenidone (Antifibrotic Agent) FORMCHECKBOX pizotifen (Serotonin and Histamine Antagonist) FORMCHECKBOX potassium acid phosphate (Urinary Acidifying Agent) FORMCHECKBOX probenecid (Uricosuric Agent) FORMCHECKBOX protein C concentrate, human (Protein C) FORMCHECKBOX prucalopride (Serotonin 5-HT4 Receptor Agonist) FORMCHECKBOX quinagolide (Hyperprolactinemia Agent, Dopamine [D2] Agonist) FORMCHECKBOX riluzole (Glutamate Inhibitor) FORMCHECKBOX riociguat (Soluble Guanylate Cyclase (sGC) Stimulator) FORMCHECKBOX ruxolitinib (Janus Associate Kinase Inhibitor) FORMCHECKBOX sacubitril and valsartan (Neprilysin Inhibitor) FORMCHECKBOX sodium oxybate (Central Nervous System Depressant) FORMCHECKBOX sulfonated phenolics and sulfuric acid (Aphthous Ulcer Treatment Agent) FORMCHECKBOX teduglutide (Glucagon-Like Peptide 1 [GLP-2]) FORMCHECKBOX tegaserod (Serotonin 5-HT4 Receptor Agonist) FORMCHECKBOX teriflunomide (Pyrimidine Synthesis Inhibitor) FORMCHECKBOX tetrabenazinde (Central Monoamine Depleting Agent) FORMCHECKBOX tolvaptan (Vasopressin Antagonist) FORMCHECKBOX uridine triacetate (Endocrine and Metabolic Agent, Miscellaneous) FORMCHECKBOX ursodiol (Gallstone Dissolution Agent) FORMCHECKBOX vasopressin (Antidiuretic Hormone Analog; Hormone, Posterior Pituitary) FORMCHECKBOX zileuton (5-Lipoxygenase Inhibitor)ADDITIONAL CATEGORIES AND/OR INDIVIDUAL DRUGS FORMTEXT ????? FORMTEXT ????? FORMTEXT ????? FORMTEXT ????? FORMTEXT ????? FORMTEXT ????? FORMTEXT ????? FORMTEXT ????? FORMTEXT ????? FORMTEXT ????? FORMTEXT ????? FORMTEXT ????? ................
................

In order to avoid copyright disputes, this page is only a partial summary.

Google Online Preview   Download